Drug Profile
ARC 520
Alternative Names: ARC-520Latest Information Update: 09 Mar 2023
Price :
$50
*
At a glance
- Originator Arrowhead Research Corporation
- Developer Arrowhead Pharmaceuticals
- Class Antivirals; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B